PRESS RELEASE published on 05/28/2024 at 18:43, 2 years 2 months ago H2APEX generated strong revenue growth in Q1 2024 and confirms revenue guidance for FY 2024 of EUR 35 million to EUR 40 million H2APEX reports strong revenue growth in Q1 2024, doubling to EUR 10.1 million. Confirms revenue guidance of EUR 35-40 million for FY 2024. Expansion plans and operations are on track Revenue Growth Revenue Guidance Green Hydrogen Plants H2APEX Q1 2024
PRESS RELEASE published on 05/22/2024 at 13:01, 2 years 2 months ago Original-Research: H2APEX Group SCA (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research bestätigt Kaufempfehlung für H2APEX Group SCA mit Kursziel von 9,00 Euro nach Veröffentlichung des Jahresberichts und Update der Schätzungen First Berlin Equity Research Kaufempfehlung H2APEX Group SCA Jahresbericht Schätzungen
BRIEF published on 05/01/2024 at 07:55, 2 years 3 months ago H2APEX Confirms Revenue Growth and Outlines Future Strategy Revenue Growth Green Hydrogen Sustainable Energy H2APEX Fiscal Report
BRIEF published on 05/01/2024 at 07:55, 2 years 3 months ago H2APEX confirme la croissance de ses revenus et présente sa stratégie future Rapport Financier H2APEX Hydrogène Vert Hausse Des Revenus L'énergie Durable
PRESS RELEASE published on 05/01/2024 at 07:50, 2 years 3 months ago H2APEX confirms both its preliminary figures for the fiscal year 2023 and its forecast for 2024 – and expects revenue to more than double H2APEX confirms preliminary figures for 2023 fiscal year and forecasts revenue to more than double in 2024, focusing on green hydrogen plants and storage solutions Storage Solutions Revenue Forecast Green Hydrogen 2023 Fiscal Year H2APEX Group SCA
PRESS RELEASE published on 03/13/2024 at 13:41, 2 years 5 months ago Original-Research: H2APEX Group SCA (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research bestätigt Kaufempfehlung für H2APEX Group SCA mit Kursziel von 9,00 Euro nach starkem Umsatzwachstum und EU-Genehmigung für Wasserstoffprojekt Kursziel Kaufempfehlung Umsatzwachstum H2APEX Group SCA EU-Genehmigung
BRIEF published on 03/05/2024 at 08:36, 2 years 5 months ago H2APEX Achieves 2023 Revenue Forecasts and Anticipates Doubling Earnings in 2024 Revenue Forecast Green Hydrogen H2APEX Financial Growth Hydrogen Plants
BRIEF published on 03/05/2024 at 08:36, 2 years 5 months ago H2APEX atteint ses prévisions de revenus pour 2023 et prévoit un doublement de ses bénéfices en 2024 Croissance Financière H2APEX Hydrogène Vert Prévisions De Revenus Usines D'hydrogène
PRESS RELEASE published on 03/05/2024 at 08:31, 2 years 5 months ago H2APEX meets forecast for the fiscal year 2023 and expects revenue to more than double in 2024 H2APEX meets forecast for fiscal year 2023, expects revenue to more than double in 2024. Company positioning for growth in green hydrogen sector Revenue Growth Green Hydrogen Forecast Financial Outlook H2APEX
PRESS RELEASE published on 02/19/2024 at 09:51, 2 years 6 months ago Original-Research: H2APEX Group SCA (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research bestätigt Kaufempfehlung und erhöht Kursziel für H2APEX Group SCA nach EU-Genehmigung von H2ERO-Projekt mit Förderung und geplantem Investitionsvolumen First Berlin Equity Research Kursziel Kaufempfehlung H2ERO-Projekt EU-Genehmigung
Published on 08/19/2026 at 14:40, 1 hour 14 minutes ago Revive Therapeutics Outlines Strategy to Build a Biodefence and Pandemic Preparedness Therapeutics Portfolio
Published on 08/19/2026 at 13:00, 2 hours 54 minutes ago UraniumX Discovery Corp. Provides Update On Transaction With Pond Technologies Holdings INC.
Published on 08/19/2026 at 13:00, 2 hours 54 minutes ago Abasca Announces Positive Preliminary Economic Assessment for the Loki Flake Graphite Deposit: After-Tax NPV of US$130 Million and 16.7% IRR
Published on 08/19/2026 at 12:30, 3 hours 24 minutes ago Wolfden Announces Positive Precious Metal Results at Canoe Landing
Published on 08/19/2026 at 09:05, 6 hours 49 minutes ago BioNxt Advances Cladribine Clinical Program with Completion of the Investigational Medicinal Product Dossier (IMPD) Ahead of Human Clinical Studies
Published on 08/19/2026 at 15:45, 9 minutes ago Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
Published on 08/19/2026 at 15:39, 15 minutes ago APM Terminals and Hapag-Lloyd partner to drive future growth at Maasvlakte II
Published on 08/19/2026 at 14:50, 1 hour 3 minutes ago EQS-Adhoc: Wolford AG announces group results for the period from January to June 2026
Published on 08/19/2026 at 14:11, 1 hour 42 minutes ago Disclosure according to Article 5(1)(b) of the EU Regulation No. 596/2014 and Article 2(3) of the Delegated EU Regulation No. 2016/1052 - 3rd Interim Report and Final Report
Published on 08/19/2026 at 14:05, 1 hour 49 minutes ago Harvey taps DeepL to power legal-grade AI translation for global law firms and legal teams
Published on 08/18/2026 at 18:00, 21 hours 54 minutes ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 22 hours 9 minutes ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 1 day 4 hours ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 1 day 4 hours ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 1 day 20 hours ago Aéroports de Paris S.A - July 2026 traffic figures